Dr Jeanette Wood joins Nuevolution as Scientific Advisor
21 September 2015 | By Victoria White
Dr Wood's expertise and experience to support Nuevolution in developing its pipeline in oncology, inflammation and immuno-oncology...
List view / Grid view
News
Selvita expands its operations into the US
21 September 2015 | By Victoria White
Appreciating the importance of the US biotechnology and pharmaceutical market, Selvita decided to come closer to its partners and clients and open a fully-owned US subsidiary, Selvita Inc...
ERManI protein prevents HIV virus from replicating
17 September 2015 | By Vicky White
By identifying ERManI as the target that slows the spread of HIV-1, researchers have revealed a target in which future therapies can be developed...
Researchers identify possible ovarian cancer biomarkers
17 September 2015 | By Victoria White
The researchers also determined that the level of biomarkers associated with ovarian cancer does not simply increase or decrease over the course of the disease...
Scientists create immunity to E. histolytica by silencing genes
17 September 2015 | By Victoria White
The new technique could be used to explore genetic mechanisms of resistance in the field of infectious disease and lead to new therapies...
Amgen and Xencor enter cancer immunotherapy and inflammation collaboration
17 September 2015 | By Victoria White
The research collaboration brings together Amgen's capabilities in target discovery and protein therapeutics with Xencor's XmAb bispecific technology platform...
Piramal encourages pharma to embrace green chemistry
17 September 2015 | By Victoria White
Piramal has launched a series of green chemistry initiatives and is asking all its partners to evaluate the greenness of the chemical pathways they are using...
CEVEC and Généthon to develop lentivirus packaging cell lines
17 September 2015 | By Victoria White
CEVEC is to grant Généthon a license for the development of lentivirus packaging cell lines based on CEVEC’s CAP GT technology...
Dementia Consortium funds project focusing on ALS and FTLD
16 September 2015 | By Victoria White
A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
USP19 inhibition protects against muscle wasting
15 September 2015 | By Victoria White
Researchers have discovered a new gene, USP19, involved in the muscle wasting syndrome cachexia that could be a good target for drug development...
Chimerix gets contract extension for smallpox treatment
15 September 2015 | By Victoria White
Chimerix has extended its contract with BARDA for the development of brincidofovir as a medical countermeasure to treat smallpox...
Auspherix and Domainex expand antibiotics partnership
15 September 2015 | By
Since initiating the project in 2014, significant progress has been made towards the invention of new compounds with activity against both gram-positive and gram-negative bacteria...
Desktop Genetics raises £1.37M to accelerate development of DESKGEN
15 September 2015 | By Victoria White
DESKGEN allows researchers to expertly design and perform CRISPR-based genome editing experiments in virtually any cell line or species...
Transatlantic partnership to develop treatments for pancreatic cancer
14 September 2015 | By Victoria White
The five-year programme will focus on the development of ‘nanomedicine’ in the treatment of pancreatic cancer, for which current treatment options are limited...
Cancer Research UK and MedImmune launch biotherapeutics research centre
14 September 2015 | By Victoria White
The new laboratory, opened in Cambridge, will focus on the discovery and development of novel biologic cancer treatments and diagnostics...
